- cafead Feb 17, 2021 at 11:22: AM
via Before mRNA vaccines became valuable preventive tools against COVID-19, scientists around the world were studying the technology's potential use in cancer therapeutics, but their success has, so far, been limited.
Now, scientists at China’s National Center for Nanoscience and Technology (NCNST) have designed a hydrogel to deliver an mRNA vaccine with an immune-stimulating adjuvant. When injected into mice with melanoma, the vaccine stayed active for at least 30 days, inhibiting tumor growth and preventing metastasis, according to results published in the American Chemical Society journal Nano Letters.
article source
Now, scientists at China’s National Center for Nanoscience and Technology (NCNST) have designed a hydrogel to deliver an mRNA vaccine with an immune-stimulating adjuvant. When injected into mice with melanoma, the vaccine stayed active for at least 30 days, inhibiting tumor growth and preventing metastasis, according to results published in the American Chemical Society journal Nano Letters.
article source